All together, these data show that the oncogenic inactivation of GSK3β by the delE746-A750EGFR or E545KPIK3CA cancer proteins significantly increases nuclear β-catenin pool in response to GD and enhances β-catenin- and FOXO4-dependent expression of genes involved in antioxidant stress response. This evidence concerns the gene GSK3B and cancer.